Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Triacontanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.93 |
| ▸ | TSHR | P16473 | 4/20 | 0.93 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
| ▸ | MEN1 | O00255 | 2/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.93 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.86 |
| ▸ | THRB | P10828 | 2/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetostearyl Alcohol SCHEMBL1643143 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Myristyl Alcohol SCHEMBL2046092 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Cetyl Alcohol SCHEMBL1101785 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Decanol SCHEMBL10594393 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Nonanol SCHEMBL2761019 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Alcohol SCHEMBL5138742 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Cetyl Alcohol SCHEMBL873050 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Docosanol SCHEMBL4958624 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Undecanol SCHEMBL4656406 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Alcohol SCHEMBL872545 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070089469-A1 | Liquid leaf fertilizer composition | TIMO HANTULA AND MARKKU HANTULA (FI) | 2007-04-26 | — | — | US | disclosed |
| EP-1646279-A1 | LIQUID LEAF FERTILIZER COMPOSITION | Hantula, Timo (FI) | 2006-04-19 | — | — | EP | disclosed |
| WO-2004107860-A1 | LIQUID LEAF FERTILIZER COMPOSITION | HANTULA, TIMO (FI) | 2004-12-16 | — | — | WO | disclosed |
| EP-0594565-A1 | USE OF C-27 TO C-32 ALIPHATIC ALCOHOLS IN ANTIVIRAL TREATMENT | LIDAK PHARMACEUTICALS (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0469064-B1 | USE OF C-20 TO C-26 ALIPHATIC ALCOHOLS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF VIRAL INFECTIONS | LIDAK PHARMACEUTICALS (US) | 1993-11-03 | — | — | EP | disclosed |
| EP-0428642-B1 | USE OF C-22 TO C-26 ALIPHATIC ALCOHOLS IN THE TREATMENT OF INFLAMMATORY AND VIRAL SKIN DISEASES | LIDAK PHARMACEUTICALS (US) | 1993-09-29 | — | — | EP | disclosed |
| US-5194451-A | Administering a Higher Aliphatic Alcohol | LIDAK PHARMACEUTICALS | 1993-03-16 | — | — | US | disclosed |
| US-5166219-A | Antiarthritic agents | LIDAK PHARMACEUTICALS (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0469064-A1 | USE OF C-20 TO C-26 ALIPHATIC ALCOHOLS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF VIRAL INFECTIONS. | LIDAK PHARMACEUTICALS (US) | 1992-02-05 | — | — | EP | disclosed |
| US-5071879-A | C20-26 aliphatic alcohol | LIDAK PHARMACEUTICALS (US) | 1991-12-10 | — | — | US | disclosed |
| US-5070107-A | SYSTEMIC ANTIVIRAL TREATMENT | LIDAK PHARMACEUTICALS (US) | 1991-12-03 | — | — | US | disclosed |
| EP-0428642-A1 | Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases. | LIDAK PHARMACEUTICALS (US) | 1991-05-29 | — | — | EP | disclosed |
| WO-1990013287-A1 | USE OF C-20 TO C-26 ALIPHATIC ALCOHOLS IN THE TREATMENT OF VIRAL INFECTIONS | LIDAK PHARMACEUTICALS (US) | 1990-11-15 | — | — | WO | disclosed |
| WO-1990013216-A2 | INFLAMMATORY DISEASE TREATMENT | LIDAK PHARMACEUTICALS (US) | 1990-11-15 | — | — | WO | disclosed |
| WO-1990013288-A1 | USE OF C-27 TO C-32 ALIPHATIC ALCOHOLS IN ANTIVIRAL TREATMENT | LIDAK PHARMACEUTICALS (US) | 1990-11-15 | — | — | WO | disclosed |
| US-4874794-A | Inflammatory disease treatment | LIDAK BIOPHARMACEUTICALS (US) | 1989-10-17 | — | — | US | disclosed |